OS5.7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma
暂无分享,去创建一个
M. Taphoorn | T. Gorlia | A. Idbaih | V. Golfinopoulos | M. Plattén | M. Bent | P. Clement | P. Mulholland | F. D. Vos | L. Lewis